BioPharma Credit PLC (LON:BPCP)
London · Delayed Price · Currency is GBP · Price in GBX 66.20
-0.10 (-0.15%)
Aug 22, 2025, 5:01 PM BST
BioPharma Credit Market Cap
BioPharma Credit has a market cap or net worth of 750.75 million as of August 22, 2025. Its market cap has decreased by -14.35% in one year.
Market Cap
750.75M
Enterprise Value
746.60M
Revenue
119.84M
Ranking
n/a
PE Ratio
7.69
Stock Price
66.20
Market Cap Chart
Since March 27, 2017, BioPharma Credit's market cap has increased from 432.35M to 750.75M, an increase of 73.64%. That is a compound annual growth rate of 6.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 750.75M | -10.44% |
| Dec 31, 2024 | 838.24M | -2.43% |
| Dec 29, 2023 | 859.07M | -17.41% |
| Dec 30, 2022 | 1.04B | 5.90% |
| Dec 31, 2021 | 982.16M | -2.00% |
| Dec 31, 2020 | 1.00B | -5.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HSBC Holdings | 167.19B |
| Barclays | 52.64B |
| Lloyds Banking Group | 49.76B |
| London Stock Exchange Group | 49.64B |
| NatWest Group | 45.35B |
| 3i Group | 39.58B |
| Standard Chartered | 31.16B |
| Prudential | 25.56B |